Xperi (NYSE:XPER – Get Free Report) and Black Titan (NASDAQ:BTTC – Get Free Report) are both small-cap services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.
Profitability
This table compares Xperi and Black Titan’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Xperi | -12.57% | -0.73% | -0.49% |
| Black Titan | N/A | -108.60% | -95.64% |
Analyst Recommendations
This is a breakdown of recent recommendations for Xperi and Black Titan, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Xperi | 2 | 0 | 2 | 0 | 2.00 |
| Black Titan | 1 | 0 | 0 | 0 | 1.00 |
Institutional & Insider Ownership
94.3% of Xperi shares are owned by institutional investors. 3.2% of Xperi shares are owned by insiders. Comparatively, 53.7% of Black Titan shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Xperi and Black Titan”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Xperi | $448.11 million | 0.60 | -$56.34 million | ($1.23) | -4.63 |
| Black Titan | $180,000.00 | 74.74 | -$4.71 million | ($2.95) | -0.50 |
Black Titan has lower revenue, but higher earnings than Xperi. Xperi is trading at a lower price-to-earnings ratio than Black Titan, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Xperi has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, Black Titan has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500.
Summary
Xperi beats Black Titan on 8 of the 14 factors compared between the two stocks.
About Xperi
Xperi Holding Corporation, together with its subsidiaries, operates as a consumer and entertainment product/solutions licensing company worldwide. It operates through two segments, Product, and Intellectual Property Licensing. The company invents, develops, and delivers various technologies. It licenses audio, digital radio, imaging, edge-based machine learning, and multi-channel video user experience solutions to consumer electronics customers, automotive manufacturers, or supply chain partners. The company also provides licensing to multichannel video programming distributors, OTT video service providers, consumer electronics manufacturers, social media, and other new media companies in media industry; and memory, sensors, RF component, and foundry companies in semiconductor industry. It provides its technologies under the DTS, HD Radio, IMAX Enhanced, Invensas, TiVo, and Perceive brands. The company is headquartered in San Jose, California.
About Black Titan
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
Receive News & Ratings for Xperi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xperi and related companies with MarketBeat.com's FREE daily email newsletter.
